Co-Dx (Co-Diagnostics, Inc.) develops advanced molecular diagnostic technology and real-time PCR testing solutions for infectious diseases and research applications.
Co-DX, corporate name Co-Diagnostics, Inc., is a molecular diagnostics company based in Salt Lake City, Utah, specializing in the development of real-time polymerase chain reaction (PCR) testing technology. The company utilizes its proprietary CoPrimer™ technology to create high-quality, cost-effective tests for detecting infectious diseases such as COVID-19, Zika, Dengue, Chikungunya, and Mpox. Their product line focuses on research use only (RUO) reagents and testing kits designed for laboratory environments.
Beyond pathogen detection, Co-Dx provides comprehensive solutions for vector control and agricultural applications. The company emphasizes accessible molecular testing through its innovative platforms, including the dedicated Co-Dx Box™ thermocycler. Co-Diagnostics is committed to advancing global health by providing reliable, state-of-the-art diagnostic tools and equipment to researchers, epidemiologists, and laboratories worldwide.
Neueste Handbücher von manuals+ Für diese Marke zusammengestellt.
Häufig gestellte Fragen zu Handbüchern, Registrierung und Support für diese Marke.
Most Co-Dx master mix reagents and components should be stored frozen, typically between -40°C and -16°C, to prevent degradation. Users should avoid repeated freeze-thaw cycles (more than four times) and protect the master mix from light.
Many Co-Dx vector control kits, such as the Vector Smart™ series, are designated as Research Use Only (RUO) and are not intended for use in diagnostic procedures.
Running Co-Dx tests typically requires a 4-channel real-time PCR instrument (such as the Co-Dx Box or Mic qPCR Cycler), a nucleic acid extraction system, a vortex mixer, a centrifuge, and adjustable pipettes with filter tips.
Safety Data Sheets for Co-Dx products can generally be retrieved directly from the resources section of the official Co-Diagnostics webWebsite.